These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9535202)

  • 1. Simultaneous determination of chlorzoxazone, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-microm porous microspherical silica-gel.
    Tanaka E
    J Pharm Biomed Anal; 1998 Jan; 16(5):899-904. PubMed ID: 9535202
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.
    Lucas D; Berthou F; Girre C; Poitrenaud F; Ménez JF
    J Chromatogr; 1993 Dec; 622(1):79-86. PubMed ID: 8120116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method.
    Leclercq I; Horsmans Y; Desager JP
    J Chromatogr A; 1998 Dec; 828(1-2):291-6. PubMed ID: 9916314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.
    Piccoli P; Carrieri M; Padovano L; Di Mare M; Bartolucci GB; Fracasso ME; Lepera JS; Manno M
    Toxicol Lett; 2010 Jan; 192(1):29-33. PubMed ID: 19900514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry.
    Wu JY; Yue J; Feng YQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):260-6. PubMed ID: 21196134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cytochrome P450 2E1 activity in microsomes by thin-layer chromatography using [2-14C]chlorzoxazone.
    Zerilli A; Lucas D; Berthou F; Bardou LG; Ménez JF
    J Chromatogr B Biomed Appl; 1996 Feb; 677(1):156-60. PubMed ID: 8925089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forensic analysis of eleven cyclic antidepressants in human biological samples using a new reversed-phase chromatographic column of 2 microm porous microspherical silica gel.
    Tanaka E; Terada M; Nakamura T; Misawa S; Wakasugi C
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):405-12. PubMed ID: 9188830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.
    Frye RF; Stiff DD
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):291-6. PubMed ID: 8971612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive high-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma.
    Stiff DD; Frye RF; Branch RA
    J Chromatogr; 1993 Mar; 613(1):127-31. PubMed ID: 8458889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population.
    Chen XP; Han XM; Jiang CH; Huang SL; Liu ZQ; Zhu B; Zhou G; Zhou HH
    Xenobiotica; 2002 Nov; 32(11):1053-62. PubMed ID: 12487734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene.
    Haufroid V; Buchet JP; Gardinal S; Lison D
    Int Arch Occup Environ Health; 2002 Sep; 75(7):453-8. PubMed ID: 12172891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of carbamazepine and its metabolites in plasma from carbon tetrachloride-intoxicated rats using a new reversed-phase chromatographic column of 2-microns porous microspherical silica gel.
    Tanaka E
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):155-60. PubMed ID: 9029326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism.
    Lee AM; Joshi M; Yue J; Tyndale RF
    Eur J Pharmacol; 2006 Dec; 552(1-3):151-8. PubMed ID: 17049344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW; Bae SK; Lee MG; Sohn YT
    J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
    Park JY; Kim KA; Park PW; Ha JM
    J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.